← FDA DRUG APPROVALS

FDA ANDA · ANDA062653

DORYX

Sponsor: WARNER CHILCOTT

APPLICATION
ANDA062653
TYPE
ANDA
ORIGINAL APPROVAL
1985-10-30
LATEST ACTION
2004-03-26
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED RELEASE
MARKETING STATUS
Discontinued

Products

DORYXDiscontinued
DOXYCYCLINE HYCLATE EQ 100MG BASE · CAPSULE, DELAYED RELEASE · ORAL

Approval history

2004-03-26Labeling · Supplement 9AP
2003-11-10Labeling · Supplement 8AP
2000-05-11Manufacturing (CMC) · Supplement 5AP
2000-03-23Manufacturing (CMC) · Supplement 4AP
1998-02-06Manufacturing (CMC) · Supplement 3AP
1997-07-31Manufacturing (CMC) · Supplement 2AP
1985-10-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →